
Sign up to save your podcasts
Or


In this episode, we explore evidence-based strategies for augmenting lithium when monotherapy fails in acute mania. Why is quetiapine the preferred add-on to valproate, despite decades of clinical tradition favoring anticonvulsants?
Faculty: David Osser, M.D. Host: Richard Seeber, M.D.
By Psychopharmacology Institute4.6
270270 ratings
In this episode, we explore evidence-based strategies for augmenting lithium when monotherapy fails in acute mania. Why is quetiapine the preferred add-on to valproate, despite decades of clinical tradition favoring anticonvulsants?
Faculty: David Osser, M.D. Host: Richard Seeber, M.D.

74 Listeners

142 Listeners

3,369 Listeners

160 Listeners

1,149 Listeners

1,349 Listeners

732 Listeners

168 Listeners

579 Listeners

473 Listeners

735 Listeners

12 Listeners

189 Listeners

150 Listeners

59 Listeners